COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Clinical trial NCT03667716 · COMPLETED

Trial details

NCT number: NCT03667716
Sponsor: Compugen Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Ovarian Cancer Breast Cancer Lung Cancer Endometrial Cancer Ovarian Neoplasm Triple Negative Breast Cancer Lung Neoplasm Neoplasm Malignant Colo-rectal Cancer

Start date: 2018-09-06
Primary completion: 2024-01-30
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.